| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/11/2004 | CA2523022A1 Nogo-b, a regulator of endothelial cell function and vessel remodeling |
| 11/11/2004 | CA2522929A1 Tissue specific promoters |
| 11/11/2004 | CA2522927A1 High throughput synthesis system and synthesizer for automatically performing the system |
| 11/11/2004 | CA2522925A1 Transgenic expression of a phytochrome a gene |
| 11/11/2004 | CA2522890A1 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through anti-sense and sense peptide nucleic acids |
| 11/11/2004 | CA2522263A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure oftarget protein, sustained-release preparation and method of producing antibody against target protein |
| 11/11/2004 | CA2520959A1 Catalyst for cleaving sugar chain |
| 11/11/2004 | CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor |
| 11/11/2004 | CA2519207A1 Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby |
| 11/10/2004 | EP1475443A2 Vectors having enhanced expression and methods of making and uses thereof |
| 11/10/2004 | EP1475442A2 Polypeptides of feline T-cell lymphotropic lentivirus |
| 11/10/2004 | EP1475441A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria |
| 11/10/2004 | EP1475440A2 Growth differentiation factor-3 |
| 11/10/2004 | EP1475439A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 11/10/2004 | EP1475438A1 Method for the preparation of antigens derived from filaggrin and their use for diagnosing rheumatoid arthritis |
| 11/10/2004 | EP1475437A1 METHOD OF EFFICIENTLY RECOMBINING ORF ENCODED BY cDNA AND TEMPLATE VECTOR, TRAP VECTOR AND PRIMER TO BE USED THEREIN |
| 11/10/2004 | EP1475436A1 Swine rag-1 gene and utilization thereof |
| 11/10/2004 | EP1475433A1 Transfection method for mammalian cells |
| 11/10/2004 | EP1475389A1 Human secreted protein that shares sequence homology with the murine Sperizin protein |
| 11/10/2004 | EP1475388A2 Novel human calcium sensitive potassium channel subunits |
| 11/10/2004 | EP1474689A2 Method of diagnosis of inflammatory diseases using calgranulin c |
| 11/10/2004 | EP1474687A2 Marks as modifiers of the p53 pathway and methods of use |
| 11/10/2004 | EP1474682A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts |
| 11/10/2004 | EP1474535A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
| 11/10/2004 | EP1474530A2 Probe correction for gene expression level detection |
| 11/10/2004 | EP1474528A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 11/10/2004 | EP1474526A2 Enzyme activation protease assay |
| 11/10/2004 | EP1474523A2 Methods of random mutagenesis and methods of modifying nucleic acids using translesion dna polymerases |
| 11/10/2004 | EP1474522A1 A method for generating engineered cells for locus specific gene regulation and analysis |
| 11/10/2004 | EP1474521A2 An herpes simplex virus complex |
| 11/10/2004 | EP1474520A2 Prkag3 gene promoter and uses thereof |
| 11/10/2004 | EP1474519A2 Microorganism for genetic therapeutic treatment of proliferative diseases |
| 11/10/2004 | EP1474518A2 Method for predicting the expression efficiency in cell-free expression systems |
| 11/10/2004 | EP1474517A2 Mutated gene coding for a lat protein and the biological applications thereof |
| 11/10/2004 | EP1474516A2 Methods of modulating cold sensory perception |
| 11/10/2004 | EP1474515A2 Regulation of human hematopoietin receptor-like protein |
| 11/10/2004 | EP1474514A1 Deoxyribozymes |
| 11/10/2004 | EP1474513A1 Signalling aptamer complexes |
| 11/10/2004 | EP1474512A2 Method to modify differentiation of pluripotential stem cells |
| 11/10/2004 | EP1474511A1 Separating method and an apparatus performing such a method |
| 11/10/2004 | EP1474508A2 Phytase variants |
| 11/10/2004 | EP1474507A2 Methods and materials for the production of organic products in cells of candida species |
| 11/10/2004 | EP1474449A2 Human antibodies for use as a therapeutic agent against vaccinia or small pox |
| 11/10/2004 | EP1474448A1 Rrp sequences and knockout mice and uses thereof |
| 11/10/2004 | EP1474446A2 Mhc class ii peptide epitope of 5t4 antigen |
| 11/10/2004 | EP1474445A1 Glycoisoforms of adiponectin and uses thereof |
| 11/10/2004 | EP1474444A1 A novel splice variant of myd88 and uses thereof |
| 11/10/2004 | EP1474442A2 Cytotoxic t-cell epitopes from chlamydia |
| 11/10/2004 | EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 11/10/2004 | EP1474434A2 The eaat2 promoter and uses thereof |
| 11/10/2004 | EP1474433A2 RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 11/10/2004 | EP1474432A1 Immunostimulatory, covalently lipidated oligonucleotides |
| 11/10/2004 | EP1474430A1 Bi-functionalised metallocenes use for marking biological molecules |
| 11/10/2004 | EP1474423A1 Heterocyclic tripeptides as hepatitis c inhibitors |
| 11/10/2004 | EP1474368A2 Novel method for production of dna biochips and applications thereof |
| 11/10/2004 | EP1474175A2 Agents that regulate apoptosis |
| 11/10/2004 | EP1474167A2 Novel proteins in enteroaggregative esheriachia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 11/10/2004 | EP1474165A1 Thermotolerant phytase for animal feed |
| 11/10/2004 | EP1474161A2 Engineered binding proteins |
| 11/10/2004 | EP1474153A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 11/10/2004 | EP1474120A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 11/10/2004 | EP1473990A2 Cardiac-specific 11 beta hydroxysteroid dehydrogenase type 2 transgenic mice |
| 11/10/2004 | EP1432983A4 Method for identifying polymorphic markers in a population |
| 11/10/2004 | EP1425045A4 Adenoviral vector and related system and methods of making and use |
| 11/10/2004 | EP1297119B1 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current |
| 11/10/2004 | EP1261617A4 Methods for assay and detection on a microarray |
| 11/10/2004 | EP1202629B1 Insect control system |
| 11/10/2004 | EP1179085A4 Method for sequencing nucleic acid molecules |
| 11/10/2004 | EP1163357A4 Primers-attached vector elongation (pave): a 5'-directed cdna cloning strategy |
| 11/10/2004 | EP1137767B1 Vectors having terminal repeat sequence of epstein-barr virus |
| 11/10/2004 | EP1131470A4 Cellular arrays and methods of detecting and using genetic disorder markers |
| 11/10/2004 | EP1012280B1 Trimerising module |
| 11/10/2004 | EP1005573A4 Dendritic nucleic acids exhibiting maximal self-assembly |
| 11/10/2004 | EP1005536B1 Microbial xyloglucan endotransglycosylase (xet) |
| 11/10/2004 | EP1003366A4 Methods for producing sialyloligosaccharides in a dairy source |
| 11/10/2004 | EP0975742B1 Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins |
| 11/10/2004 | EP0839186B1 A modified enzyme with lipolytic activity |
| 11/10/2004 | EP0836611A4 Sequences for production of 2,4-diacetylphloroglucinol and methods |
| 11/10/2004 | EP0760852B1 Immunosuppressant target proteins |
| 11/10/2004 | EP0658206B1 Inhibitor resistant serine proteases |
| 11/10/2004 | EP0638173B1 Optical and electrical methods for molecule detection |
| 11/10/2004 | CN1545561A Configurable dynamic three dimensional array |
| 11/10/2004 | CN1545554A Modification of plant genomes |
| 11/10/2004 | CN1545553A Method for producing recombinant trypsin |
| 11/10/2004 | CN1545552A Genes and proteins, and their uses |
| 11/10/2004 | CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 11/10/2004 | CN1545550A Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 11/10/2004 | CN1545548A Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 11/10/2004 | CN1545521A Peptide as antagonist of VEGF receptor Flt-1 |
| 11/10/2004 | CN1545424A Anti-cancer medicine comprising disintegrin genes and treating methods thereof |
| 11/10/2004 | CN1544641A Method for improving plant nutrition quality utilizing gene engineering technology |
| 11/10/2004 | CN1544640A Expression method for high temperature resistant xylanase and specific expression carrier for same |
| 11/10/2004 | CN1544639A Eukaryon general expression carrier system as in-vitro detection reagent and construction method thereof |
| 11/10/2004 | CN1544638A Virus-like particle capable of carrying and loading polypeptide |
| 11/10/2004 | CN1544637A Method for preparing mB7.1-GPI fusion proteins and their uses |
| 11/10/2004 | CN1544636A Preparation and identification method for aldose reductase-like protein (ARL-1) monoclonal antibody |
| 11/10/2004 | CN1544635A Highly efficient expression of bacillus foecalis alkaligenes penicillin G acylated enzyme in colibacillus |
| 11/10/2004 | CN1544634A Plant low-phosphorus resistant genes, encoded protein and application thereof |
| 11/10/2004 | CN1544633A Plant low-kalium resistant genes, encoded protein and application thereof |
| 11/10/2004 | CN1544632A Gene associated with plant salt resistance and drought resistance, encoded protein and application thereof |